Clinical trial
Hyperphenylalaninemia in Cerebral Malaria
NCT00338520 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00338520 |
|---|---|
| Title | Hyperphenylalaninemia in Cerebral Malaria |
| Official title | Hyperphenylalaninemia in Cerebral Malaria |
| Lead sponsor | University of Utah, Other |
| Collaborators | Hubert Kairuki Memorial University Duke University National Institutes of Health (NIH) NIH National Institute of Allergy and Infectious Diseases (NIAID) |
| Status | Completed |
| Study type | Observational |
| Conditions | Plasmodium Falciparum Malaria |
| Enrollment | 285 |
| Start date | Oct 1, 2007 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | Jun 20, 2006 |
| Last update posted | Oct 22, 2012 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: